# Spironolactone for Pulmonary Arterial Hypertension

> clinical trial · VERIFIED · 2026-07-08

Status: RECRUITING · Sponsor: National Institutes of Health Clinical Center (CC) · Condition: Pulmonary Arterial Hypertension

- Company: National Institutes of Health Clinical Center (CC)
- Sector: cardiology
- Primary source: https://clinicaltrials.gov/study/NCT01712620

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.